Axe Compute Inc. (AGPU) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US74039M4087
Axe Compute Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 125,284.00 USD |
| Gross profit | 52,662.00 USD |
| Operating income | -180.92 m USD |
| EBIT | -233.10 m USD |
| Net income | -233.10 m USD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Axe Compute Inc.
Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
More stocks
- New Era Electronics Co Ltd (4909.TWO)
- UWHARRIE CAPITAL CORP (UWHR)
- Naintech Co. Ltd. (267320.KQ)
- Yew Lee Pacific Group Berhad (0248.KL)
- Wooyang HC Co., Ltd. (101970.KQ)
- Biosolution Co.Ltd (086820.KQ)
- UNITRAD (0247.KL)
- Impact Develop (IMP.RO)
- TuHURA Biosciences, Inc./NV (HURA)
- United Recommend International Co Ltd (5321.TWO)
- LAKELAND INDUSTRIES INC (LAKE)
- IMMUCELL CORP /DE/ (ICCC)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.